from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2993c/-

LFCtreatmentdescriptionclass of inhibitor

-0.285

Amikacinug/mL Amikacintranslation

1.356

Cap5-10ug/mL Capreomycintranslation

0.638

Rox10-50 ug/mL Roxithromycintranslation

0.868

SM2-5 ug/mL Streptomycintranslation

0.471

Tet5-10 ug/mL Tetracyclinetranslation

0.334

Rif0.2-5ug/mL Rifampicintranscription

-0.009

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.019

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.035

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.605

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.123

Clofazimine10-13 ug/mL Clofaziminerespiration

0.572

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.170

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.787

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.058

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.407

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.033

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.429

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.905

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.423

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.445

KCN5-20 ug/mL Potassium cyaniderespiration

-0.109

NaN30.2-2 mM Sodium aziderespiration

1.266

Nigericin50 uM Nigericinrespiration

-0.950

TRC10-150 ug/mL Triclosanrespiration

-1.774

TRZ10-25 ug/mL Thioridazinerespiration

-0.955

Valinomycin0.5-10 uM Valinomycinrespiration

0.911

ZnSO42 mM ZnSO4respiration

-0.098

menadione6-10 ug/mL Menadionerespiration

-0.155

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.852

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.636

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.065

NRP_1Non-replicating persistence stage 1dosRassociated

0.794

Amp0.2mg/mL AmpicillincellWall

0.482

Cephalexin20-100 ug/mL CephalexincellWall

0.842

Cerulenin0.32-5 ug/mL CerulenincellWall

0.494

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.176

EMB10-20 ug/mL EthambutolcellWall

0.216

Eta12-40 ug/mL EthionamidecellWall

-0.061

INH0.2-0.4 ug/mL IsoniazidcellWall

0.849

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.540

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.536

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.818

BZA0.12 mg/mL BenzamidearomaticAmides

-0.655

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.083

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.058

H2O24 mM hydrogen peroxideDNAdamaging

0.481

Levo10 ug/mL LevofloxacinDNAdamaging

0.251

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.931

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.807

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.174

UVUV-irradiationDNAdamaging

-1.575

ARP41-4 ug/mL Antitubercular compound ARP4?

0.756

Antimycin12.5-50 ug/mL Antimycin A?

1.036

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.648

PA_110-50 ug/mL Antitubercular compound PA-1?

0.519

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.287

PA8240.2-2 ug/mL PA-824?

-1.339

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.008

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.358

Verapamil50 uM Verapamil?

0.691

mercaptoethanol2 mM 2-Mercaptoethanol?

1.310

methoxatin10-20 ug/mL Methoxatin?